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a  b  s  t r  a  c  t
Process  analytical  technologies  (PAT)  for the  manufacturing  of  biologics  have  drawn  increased  interest
in  the  last  decade.  Besides  being  encouraged  by the  Food  and  Drug  Administration’s  (FDA’s)  PAT ini-
tiative,  PAT  promises  to improve  process  understanding,  reduce  overall  production  costs  and  help to
implement  continuous  manufacturing.  This  article  focuses  on  spectroscopic  tools  for  PAT in downstream
processing  (DSP).  Recent  advances  and  future  perspectives  will be reviewed.  In  order to exploit  the  fulleywords:
ownstream processing
rocess analytical technology
pectroscopy
hemometrics
potential  of  gathered  data,  chemometric  tools  are  widely  used  for  the evaluation  of complex  spectroscopic
information.  Thus,  an  introduction  into  the  ﬁeld  will  be given.
© 2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/4.0/).iologics
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. Introduction
In 2004, the United States’ FDA published Guidance for indus-
ry. PAT – A framework for innovative pharmaceutical development,
to process control, i.e. to be taken actively into account for pro-
cess decisions. While being intended for both small molecules and
biologics, the implementation into these two domains of pharma-
ceuticals is advancing at different paces. In the past, PAT was
adopted more quickly in the production of small molecules. ForPlease cite this article in press as: M.  Rüdt, et al., Advances in downstre
analytical technology, J. Chromatogr. A (2016), http://dx.doi.org/10.10
anufacturing and quality assurance [1]. Within the guidance, FDA
romotes the implementation of PAT into all unit operations to
onitor critical quality attributes (CQAs). PAT is described as being
art of process design and furthermore intended to contribute
∗ Corresponding author.
E-mail address: juergen.hubbuch@kit.edu (J. Hubbuch).
ttp://dx.doi.org/10.1016/j.chroma.2016.11.010
021-9673/© 2016 The Authors. Published by Elsevier B.V. This is an open access article uan extensive review thereof, the authors defer to [2]. This article
will focus on biologics only.
In contrast to most small molecules, biologics are produced
in living organisms which are very sensitive to a wide variety ofam processing of biologics – Spectroscopy: An emerging process
16/j.chroma.2016.11.010
external factors. Most biologics are complex proteins. They do not
consist of one chemical entity but a distribution of many species.
Already slight process changes can affect the product quality proﬁle
[3]. In order to ensure a consistent product quality and to reduce
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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atch-to-batch variability, PAT for biologics is of great interest
4–8]. Furthermore, current trends towards continuous manufac-
uring may  require an improved process control for keeping a
teady state over prolonged periods of time. Such a control may  be
impliﬁed by the possibility to monitor critical quality attributes in
eal-time [9].
Other advantages of PAT include the simpliﬁcation of root cause
nalysis [10] and improvement of process understanding. Eventu-
lly, the improved process understanding and real-time monitoring
apabilities may  lead to the implementation of the concept of real-
ime release [1]. Thus, the CQA proﬁle of the ﬁnal product can be
uaranteed to lie within acceptable quality limits solely based on
eal-time measurements and production batches can be released
ased on this data.
Early approaches to PAT for biologics widely addressed the prob-
em by implementing on-line analytical chromatography. Already
efore the release of the PAT guidance, on-line high performance
iquid chromatography (HPLC) has been used to control column
oading and pooling decisions during chromatographic puriﬁcation
teps [11,12]. Subsequently, on-line and at-line HPLC was further
sed for a variety of applications [13–15]. Recently, at-line HPLC has
een also implemented in the control of continuous chromatog-
aphy equipment [16]. HPLC provides high resolution of different
pecies. However, it is complex regarding the required equipment,
onsisting of a device for sampling as well as the chromatograph
tself. This may  be undesirable in a manufacturing environment as
eliability may  be an issue. Furthermore, automated sampling and
he analytical separation also lead to non-negligible time delays.
epending on the decision time of a unit operation, this may lead
o late notice of process deviations or even completely prevent
eal-time monitoring.
Spectroscopy is a powerful tool for process monitoring [17].
pectroscopic equipment has similar investment costs ($20k to
200k) as on-line HPLC. Measurement times are fast, typically in
he subsecond range up to a few minutes. Furthermore, measure-
ents can often readily be performed in-line. Fast measurement
imes are especially important for preparative chromatography,
he workhorse in current DSP. Preparative chromatographic pro-
esses are highly non-linear and feature sharp concentration fronts
18]. Thus, CQAs of the efﬂuent such as the mass fraction of impu-
ities are quickly changing. To reliably control such processes, the
sed monitoring method needs to have short response times. Typ-
cal decision times for preparative protein chromatography lie in
he range of 30 s to several minutes. In contrast to at-line HPLC,
pectroscopy provides signals with limited selectivity for different
omponents. To overcome this limitation, a combination of mul-
ivariate measurements and mathematical tools for multivariate
ata analysis (MVDA) is generally applied to extract information
rom spectroscopic measurements.
Following this argumentation, this article is focusing in a ﬁrst
art on the review of two widely used chemometric tools for the
nalysis of spectroscopic data. Subsequently, the current state-of-
rt of spectroscopic PAT in DSP is discussed.
. Multivariate data analysis for PAT
The implementation of the PAT framework is often accompa-
ied by the application of multivariate mathematical approaches
1], also known as chemometrics. In chemometrics, mathematical
nd statistical tools are used to extract useful chemical informa-
ion from large amounts of multivariate measurements or raw dataPlease cite this article in press as: M.  Rüdt, et al., Advances in downstre
analytical technology, J. Chromatogr. A (2016), http://dx.doi.org/10.10
19]. The multivariate nature of spectroscopic data for PAT arises
ut of necessity, since no univariate process analyzer has signif-
cant selectivity to monitor a speciﬁc CQA without interferences
rom other properties [17]. Chemometrics can be used for a wide PRESS
. A xxx (2016) xxx–xxx
variety of tasks, including experimental design (DoE) and MVDA
[20]. The present article does not aim to give a complete review of
all elements in chemometrics, but focuses solely on MVDA. Further-
more, only the two  most common MVDA tools in PAT are discussed
more closely: principal component analysis (PCA) and partial least
squares regression (PLS). A more thorough review of chemometric
tools is given in the textbook of Bakeev [17].
2.1. Multivariate projection methods
Multivariate projection (decomposition) to latent structures
forms the basis of many approaches in MVDA [21]. According
to Kvalheim [22,23], the latent variable (LV) projection of a data
matrix X = (x1, . . ., xk), with n observations and k variables, can
most easily be understood by reference to variable and objective
space, as illustrated in Fig. 1. The former case (Fig. 1a) reveals
relationships between observations by plotting the observations
in a space spanned by the k variables in X. In the object space
(Fig. 1b), the coordinate system is deﬁned by the n observations.
It visualizes information about the relationship between variables
[22]. The main goal of latent projection methods is to reduce the
dimensions in the variable space by summarizing variables with
similar information in LVs. All latent projection methods help get-
ting fundamental insights into complex multivariate data by (1)
discovering groupings in the data, (2) data compression, (3) regres-
sion, and more [24].
The variable decomposition into LVs can geometrically be inter-
preted as a projection of the data in the variable and object space on
a-dimensional hyperplanes, whereby a represents the number of
LVs. Since the projection is performed in both spaces, the maximum
number of LVs is min(n, k). The projection coordinates (scores) of
the observations in the variable space on the ith LV are summarized
in the score vector ti and are obtained by projecting the samples on
the corresponding weight vector wi [23]. The vectors ti and wi are
orthogonal and orthonormal, respectively. Any latent projection
method can be derived over the deﬁnition of wi [20]. The projec-
tion coordinates (loadings) of the variables in the object space are
summarized in the loading vector pi. The loading vectors pi are not
necessarily orthogonal.
2.2. Principal component analysis
PCA is a common tool in exploratory data analysis and is used for
data reduction, simpliﬁcation, outlier detection, classiﬁcation, and
noise reduction [25]. Data decomposition of a matrix X according
to
X = TPT + EX (1)
is performed with the objective to explain as much as of the vari-
ance in X by a linear combination of a complementary set of scores
T = (t1, . . ., ta) and loadings P = (p1, . . ., pa). In order to differen-
tiate the data decomposition by PCA from other latent projection
methods, the LVs are referred to as principal components (PCs). In
PCA, the loadings pi are equal to the weights wi and thus orthonor-
mal. They give a quantitative measure of the part of variance
and observed variable shares with the PC [22]. Thus, the whole
information regarding the linear relationship between variables is
compressed in the loading matrix P. The hidden structure of X con-
cerning the object space can be visualized by loading plots, where
the loadings pi are plotted against each other [25]. Variables hav-
ing similar loading values on a PC are linear dependent (collinear)
and are redundant concerning this PC. For mean centered data, asam processing of biologics – Spectroscopy: An emerging process
16/j.chroma.2016.11.010
illustrated in Fig. 1, collinearity between two variables can graph-
ically be visualized by the cosine of the angle between the two
variables in the object space. In the same manner as relationships
between variables can be illustrated by loading plots, relationships
ARTICLE IN PRESSG ModelCHROMA-358040; No. of Pages 8
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Pig. 1. Visualization of a data matrix X consisting of three observations with three v
re  projected on a latent structure deﬁned by the weight vectors wi , leading to the p
bject  space are summarized in the loading vectors pi .
etween observations can be visualized by score plots [25]. Score
lots can reveal patterns, clusters, and outliers in the observations
measurements). Usually, two or three PCs are already sufﬁcient
o reveal hidden patterns in X by loading and score plots, since the
ost useful information (variance) in X is explained by the ﬁrst few
Cs. The remaining ones are assumed to comprise predominantly
oise [25]. By neglecting these minor PCs, PCA achieves a data sim-
liﬁcation and noise reduction in X. Since both scores and loadings
re orthogonal, PCA is also able to reduce collinearity in X, which is
hy it also plays a central role in regression analysis.
.3. Partial least square regression
Linear regression methods like PLS are tools in exploratory data
nalysis, relating one or more response variables Y with several
redictor variables X, by a linear multivariate model
 = XB + EY (2)
here B contains the regression coefﬁcients connecting the pre-
ictor variables to the responses. The deviation between model
esponses and measurements is summarized in the residual matrix
Y. In the simplest case, when the matrix X is of full rank, mul-
iple linear regression (MLR) can be applied and the regression
oefﬁcients can be obtained by the least square solution
 = (XTX)−1XTY. (3)
In most PAT applications, however, the observation to variable
atio is rather low and the X-variables are collinear and noisy. In
uch cases, prediction abilities of MLR  models can be very poor
ince the estimated regression coefﬁcients become unstable and
an deviate substantially from their expected values [26,27].
An alternative way to determine the regression coefﬁcients B
s by using latent projection methods like principal component
egression (PCR) and PLS. In PCR the collinearity problem is solved
y (1) decomposing the predictor matrix X to orthogonal PCs and (2)
egressing the responses Y on the orthogonal scores T instead of X.
he score matrix T is of full rank and allows the prediction of stable
egression coefﬁcients. Furthermore, data decomposition prior to
egression allows noise reduction and thus the calibration of more
obust models. A major drawback of PCR is that data decomposition
s performed under the objective to explain as much as possible ofPlease cite this article in press as: M.  Rüdt, et al., Advances in downstre
analytical technology, J. Chromatogr. A (2016), http://dx.doi.org/10.10
he variance in X. However, the variance in X that is relevant for the
rediction of Y could be rather small in comparison with the total
ariance in X. Thus, much of the relevant variance could be lost by
CA [17].les in the variable space (a) and object space (b). Observations in the variable space
tion coordinates (scores) ti . Projection coordinates (loadings) of the variables in the
In contrast to PCR, PLS performs a simultaneous decomposition
of X and Y with the objective to explain as much as possible of the
covariance between the data sets [28]. The decomposition of X and
Y can be described by
T = XW (4)
and
Y = UCT + EC (5)
where U = (u1, . . ., ua) contains the corresponding Y-scores ui on
the ith latent variable, EC represents the Y-residuals, and C =
(c1, . . ., ca) denotes the linear transformation deﬁned by the ortho-
gonal Y-loadings ci. Since the weight matrix W is determined under
the objective of maximizing covariance between X and Y, the scores
T are good predictors of the original data X
X = TPT + EX (6)
and model also the responses [29]
Y = TCT + EY . (7)
In contrast to PCA, weights wi and loadings pi are not equal. The
orthonormal weights can be considered as tilted X-loadings since
they describe the effective relationship between X and Y. Depending
on how strong Y effects W,  the weights wi deviate more or less
from the loadings pi [30]. The X-loadings are not orthogonal to each
other [24]. Comparing Eq. (2) with Eq. (7) leads to the regression
coefﬁcient
B = WCT. (8)
Since the regression model B is calculated from the orthogonal
latent structures W and C, PLS is able to analyze data with strongly
collinear, noisy, and numerous X-variables [29].
3. Spectroscopy for process monitoring in chromatography
In the past, spectroscopic methods have been widely used as
tools for structural analysis of proteins [31–33]. From a biochemical
point of view the analysis of proteins can be split into the assess-
ment of primary, secondary, tertiary and quaternary structures.
Spectroscopic methods provide information about each of these
layers of abstraction within the protein structure (cf. Fig. 2) [31].am processing of biologics – Spectroscopy: An emerging process
16/j.chroma.2016.11.010
To assess the sequence and total concentration of protein, espe-
cially UV/vis spectroscopy and Fourier-Transform Infrared (FTIR)
spectroscopy are of interest. UV/vis spectroscopy mainly measures
the primary structure, i.e. the content of aromatic amino acids as
Please cite this article in press as: M.  Rüdt, et al., Advances in downstream processing of biologics – Spectroscopy: An emerging process
analytical technology, J. Chromatogr. A (2016), http://dx.doi.org/10.1016/j.chroma.2016.11.010
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ell as weak spectral shifts due to the solvochromatic effects [31].
he secondary structure of proteins has been frequently measured
y vibrational spectroscopy such as FTIR and Raman spectroscopy
32,34,35]. The methods allow to measure the vibrational modes of
he backbone of polypeptides. The tertiary structure of proteins is
ccessible over the ﬂuorescence of the aromatic amino acids. The
ryptophan emission is solvatochromatic, reacting to changes in
he local polarity around tryptophan residues [31,33]. Thus, struc-
ural changes which affect the local environment of tryptophan
esidues can be detected by ﬂuorescence spectroscopy. Finally, the
uaternary structure of proteins, i.e. assembly of multiple subunits
r native aggregation of protein monomers, may  be assessed over
he protein size by quasi-elastic light scattering methods includ-
ng static light scattering (SLS) and dynamic light scattering (DLS)
31,4].
All of the above mentioned methods are of major interest for
rocess monitoring as each method provides access to orthogonal
nformation about the product. Key aspects of the different meth-
ds have been summarized in Table 1. In literature, especially
V/vis absorption and FTIR have been used for a variety of PAT
pplications (cf. Sections 3.1 and 3.2). Literature for ﬂuorescence
pectroscopy as well as DLS is less broad. However interesting
pplications exist (cf. Section 3.3). In the following sections, the
ifferent applications will be discussed.
.1. UV/vis spectroscopy
UV/vis spectroscopy measures the absorption of proteins gen-
rally in the range between 240 and 340 nm. Mainly due to
he content of aromatic amino acids (phenylalanine, tyrosine,
nd tryptophan) proteins signiﬁcantly absorb in this region (cf.
ig. 2, primary structure) [18,31,36]. Due to the sensitivity, repro-
ucibility of signals and robustness of the spectrometers, UV/vis
bsorption at 280 nm is widely used as a primary detection method
f protein concentrations. While current applications mainly rely
n univariate UV/vis measurements, it has been shown that UV/vis
pectra contain a signiﬁcant amount of information on proteins and
ay  be used for selective quantiﬁcation even if only minute spectral
ifferences exist [36].
Multivariate UV/vis spectroscopy in conjunction with PLS mod-
ling for selective protein quantiﬁcation ﬁrst appeared in 1994 [37].
rteaga et al. demonstrated the quantiﬁcation of the three main
ovine caseins by PLS regression on the fourth derivative UV/vis
pectra. The PLS model was calibrated based on designed mixing
atios. In contrast to latter publications which focus on (near)-real-
ime assays, Areaga et al. intended the proposed method as an
ff-line analytical assay. In the scope of the publication, the method
as not applied to process samples.
The ﬁrst at-line application for chromatography was  only
eported in 2011 as a tool to circumvent the analytical bottle-
eck created by high throughput experimentation [38]. Similar to
rteaga et al., a PLS model was calibrated based on designed mixing
atios of pure protein components. The calibrated PLS model was
sed to selectively quantify the protein content in elution fractions
f multiple co-eluting species from miniaturized and parallelized
hromatography experiments. The results were later conﬁrmed byPlease cite this article in press as: M.  Rüdt, et al., Advances in downstre
analytical technology, J. Chromatogr. A (2016), http://dx.doi.org/10.10
39]. Subsequently, the method was transferred to an in-line setup
ith a diode array detector and applied for a selective and real-
ime quantiﬁcation of 3 model proteins [40]. It was shown that the
econvoluted signal from the detector could be directly used in
ig. 2. Based on the example of ovomucoid, the four different level of protein structure a
xplaination of what is measured. The lists are not extensive but rather correspond to the
D:  1OVO [53,54]. UV/vis spectra obtained from [36]. PRESS
. A xxx (2016) xxx–xxx 5
a feed-forward controller to trigger product pooling. Experiments
were performed in diluted conditions to prevent detector satura-
tion.
While the above mentioned publications provided accurate pre-
dictions of protein concentrations in multi-protein mixtures, they
all relied on designed mixing ratios of pure proteins. This may
pose major difﬁculties when calibrating a PLS model for an applied
example, e.g. the puriﬁcation of a monoclonal Antibody (mAb)
from its high molecular weight impurities (HMWs). Brestrich et al.
addressed this problem by using process based samples for the
PLS model calibration [41]. Instead of using pure protein sam-
ples to produce designed mixing ratios, chromatographic runs at
variable conditions were performed to span a model calibration
space. The column efﬂuent of those experiments was fraction-
ated and analyzed by suitable off-line analytics. They applied the
newly designed method to different diluted separation problems
including the separation of a mAb  from its impurities and the mea-
surement of different protein species in human blood fractionation.
Since then, UV/vis spectroscopy in conjunction with PLS mod-
eling has been used in multiple studies. As a supportive tool, it was
applied together with mechanistic modeling for a generic root-
cause investigation [10]. In a ﬁrst preparative in-line application,
the tool has been used to monitor and control a chromatographic
Protein A capture step, an application which may  be of interest
for controlling continuous chromatography equipment [42]. Cur-
rent research aims to extend the applicable concentration range for
the approach. During the elution of preparative chromatographic
steps, very high protein concentrations may  occur and cause detec-
tor saturation in the UV/vis range. By applying variable pathlength
spectroscopy, the linear range of UV/vis absorption spectroscopy
can be greatly extended. PLS modelling allowed the deconvolution
of co-eluting species in multiple case studies [43].
3.2. FTIR spectroscopy
FTIR spectroscopy is frequently applied as a PAT technology for
small molecule production [2]. For proteins, FTIR was ﬁrst estab-
lished as a tool for assessing the secondary structure [31,32,34,35].
Proteins are detected by the vibration of the polypeptide backbone.
Multiple vibrational modes correspond to different detected amide
bands (cf. Fig. 2, primary and secondary structure). The absorp-
tion of the amide bands is directly proportional to the amount of
polypeptide backbone. The most prominent proteinogenic band,
the amide I band, is mainly caused by C O stretching. Secondary
structural elements induce band shifts of the amide bands. This
phenomenon can be used to quantify the proportion of different
secondary structural elements, e.g. by taking the second derivative
or applying Fourier self-deconvolution. Thus, FTIR is a promis-
ing candidate for monitoring the overall protein mass as well as
the structural integrity of proteins by their secondary structure.
The application is however hindered by the strong absorption
of water in the same spectral region. It is a non-trivial task to
correct for the water absorption. To prevent total extinction in
the transmission cell, typical pathlengths need to be very short
(approximately 5 m), which however also reduces the sensitiv-
ity towards proteins. Despite the existing problems, a number ofam processing of biologics – Spectroscopy: An emerging process
16/j.chroma.2016.11.010
promising applications have been reported.
Publications demonstrated the possibility to selectively detect
mAbs, HMWs  and host cell proteins (HCPs) [44,45] with FTIR for
biopharmaceutical applications. Experiments were performed in
re illustrated. To each level, suitable spectroscopic methods are listed with a short
 most promising methods in the authors eyes. Protein structure retrieved from PDB
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Table 1
Summary of different spectroscopic methods of interest with key information on each method.
Spectroscopic
method
Wavelength
range
Acquisition
time
Signal-to-noise
ratio
Measured attribute Remarks References
UV/vis
spectroscopy
240–340 nm 0.01–30 s + Mainly aromatic amino
acids
Sensitive, quantitative,
simple instrumentation
[10,31,36–38,40–43]
Mid-IR 2.5–25 m Single scan
0.5–4 s
– – Peptide backbone Strong water bands, for
high signal-to-noise ratios
multiple scans (100–600)
are necessary
[32,34,45,44,46–48]
Near-IR 0.8–2.5 m Single scan
0.5–4 s
– Vibrational overtones
of peptide backbone
Strong water bands, low
sensitivity, low selectivity,
simple instrumentation,
ﬁber probes readily
available
[17]
Raman
spectroscopy
Depends on
excitation laser
Depends on
excitation laser
– – Peptide backbone Generally low sensitivity,
high selectivity, not
infringed by water
absorption, ﬁber probes
readily available
[31,34]
Fluorescence
spectroscopy
Excitation:
240–300 nm
Emission:
260–450 nm
0.01–300 s ++ Aromatic amino acids
and their
solvochromatic
environment
Broad measurement ranges
feasible, calibration may  be
challenging
[33,31,49]
DLS Visible light,
e.g. 633 nm
0.5–8 min  – Diffusion behaviour of
macromolecules
Based on time correlation,
limited suitability for
ﬂow-through
[50]
SLS Visible light, <1 s – Light scattering due to
p
Difﬁcult to obtain stable [31]
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De.g. 633 nm
Circular
dichronism
190–260 nm <1 s + 
n at-line setup. The approach was later extended to further down-
tream processing unit operations [46]. Capito et al. demonstrated
he use of a calibrated PLS model to selectively quantify mAb, HMW
nd HCP concentrations of samples drawn from different unit oper-
tions. Again experiments were performed at-line. mAb  could be
uantiﬁed down to concentrations of 0.7 g/l while HMW  concen-
rations as low as 1% [w/w] were detected.
During the refolding process of an inclusion body of an auto-
rotease, FTIR was applied as an in-line PAT tool to monitor the
elative content of different secondary structural elements [47]. A
ime evolution of the relative content of structural elements could
e shown during the refolding process. However, the results did
ot allow prediction of the refolding yield based on the computed
ontent of secondary structural elements.
Recently, an approach was published to monitor the in-column
inding behaviour of mAb  during a Protein A capture step by FTIR
48]. A micro-column was packed on top of an attenuated total
eﬂection (ATR) crystal. With a PLS model, the total protein content
f resin in contact with the ATR crystal was measured over multi-
le process steps. The publication showed, that the clean-in-place
teps do not seem to be able to reliably remove all bound protein.
hile being an interesting scientiﬁc approach, a transfer to a larger
cale system may  be difﬁcult. The proposed setup samples the resin
ery locally, which may  not be representative for the overall col-
mn. Furthermore, lateral stress had to be applied to generate an
ncreased contact area between resin and ATR crystal. Nevertheless,
he approach shows the versatility of FTIR spectroscopy.
.3. Other spectroscopic PAT tools
To the best of our knowledge, other spectroscopic methods have
nly been studied by two articles as PAT technologies for DSP of
iologics. Fluorescence spectroscopy was proposed as an at-line
AT tool for a chromatographic puriﬁcation step of a fusion pro-Please cite this article in press as: M.  Rüdt, et al., Advances in downstre
analytical technology, J. Chromatogr. A (2016), http://dx.doi.org/10.10
ein [49]. Here, it was shown that the ﬂuorescence signal could
e correlated with the fraction purity from an hydrophobic inter-
ction chromatography step separating misfolds from the product.
LS was used to investigate the unfolding and refolding process of aarticle size baselines
hirality of secondary
tructure
Impractical at high
concentrations
[31]
recombinant fusion protein from an inclusion body and its depend-
ence on a chaotropic agent [50]. Yu et al. could accurately predict
the aggregation and folding state compared to reference analyt-
ics. The method was  however not applied for real-time process
monitoring or control.
4. Conclusion and outlook
In summary, PAT for biologics has advanced in recent years
towards real-time monitoring and control of critical quality
attributes. Spectroscopy based PAT tools have been success-
fully applied to a variety of applications. Compared to other
methodologies, they feature fast measurement times, easy in-line
implementation and maintainable costs.
A major challenge in future relates to a ﬂexible implementation
of PAT tools into different unit operations. Currently, disposable
and single-use technologies are gaining market shares especially
during clinical phases [51]. At the same time, the product port-
folio of biologics is broadening. New formats such as antibody
fragments, nanobodies, conjugated proteins and vaccines, and Fc-
fusion proteins are emerging [52]. Depending on the unit operation
and biopharmaceutical product, different sensors or sensor com-
binations may  be of interest. Ideally, detectors could therefore
be exchanged with little effort. Such a ﬂexible approach to PAT
however requires standardized communication between different
components, e.g. through OPC Foundation’s OPC uniﬁed architec-
ture (OPC UA). Here, the support of the equipment manufacturer as
well as dedicated sensor manufacturer is key [17]. By providing a
ﬂexible platform which allows to combine different manufacturing
equipment with a range of sensor technologies, a versatile approach
towards future PAT challenges could be implemented.
Acknowledgementsam processing of biologics – Spectroscopy: An emerging process
16/j.chroma.2016.11.010
This work has received funding from the European Union’s
Horizon 2020 research and innovation programme under grant
agreement No. 635557.
 ING ModelC
atogr
m
a
m
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[ARTICLEHROMA-358040; No. of Pages 8
M. Rüdt et al. / J. Chrom
The authors would like to thank Sebastian Andris, Dr. Pascal Bau-
ann and Stefan Heissler for the review of the manuscript. They
re also thankful for the valuable inputs they received from other
embers of the research group MAB  at KIT.
eferences
[1] FDA, Guidance for Industry. PAT – A Framework for Innovative
Pharmaceutical Development, Manufacturing, and Quality Assurance, 2004.
[2] L.L. Simon, H. Pataki, G. Marosi, F. Meemken, K. Hungerbühler, A. Baiker, S.
Tummala, B. Glennon, M.  Kuentz, G. Steele, H.J.M. Kramer, J.W. Rydzak, Z.
Chen, J. Morris, F. Kjell, R. Singh, R. Gani, K.V. Gernaey, M. Louhi-Kultanen, J.
Oreilly, N. Sandler, O. Antikainen, J. Yliruusi, P. Frohberg, J. Ulrich, R.D. Braatz,
T.  Leyssens, M. Von Stosch, R. Oliveira, R.B.H. Tan, H. Wu,  M.  Khan, D. Ogrady,
A.  Pandey, R. Westra, E. Delle-Case, D. Pape, D. Angelosante, Y. Maret, O.
Steiger, M.  Lenner, K. Abbou-Oucherif, Z.K. Nagy, J.D. Litster, V.K. Kamaraju,
M.S. Chiu, Assessment of recent process analytical technology (PAT) trends: a
multiauthor review, Organ. Process Res. Dev. 19 (1) (2015) 3–62, http://dx.
doi.org/10.1021/op500261y.
[3] M.  Schiestl, T. Stangler, C. Torella, T. Cˇepeljnik, H. Toll, R. Grau, Acceptable
changes in quality attributes of glycosylated biopharmaceuticals, Nat.
Biotechnol. 29 (2011) 310–312.
[4] S. Flatman, I. Alam, J. Gerard, N. Mussa, Process analytics for puriﬁcation of
monoclonal antibodies, J. Chromatogr. B 48 (1) (2007) 79–87.
[5] J. Glassey, K.V. Gernaey, C. Clemens, T.W. Schulz, R. Oliveira, G. Striedner, C.-F.
Mandenius, Process analytical technology (PAT) for biopharmaceuticals,
Biotechnol. J. 6 (4) (2011) 369–377.
[6] S. Challa, R. Potumarthi, Chemometrics-based process analytical technology
(PAT) tools: applications and adaptation in pharmaceutical and
biopharmaceutical industries, Appl. Biochem. Biotechnol. 169 (1) (2013)
66–76.
[7] S.M. Mercier, B. Diepenbroek, R.H. Wijffels, M.  Streeﬂand, Multivariate PAT
solutions for biopharmaceutical cultivation: current progress and limitations,
Trends Biotechnol. 32 (6) (2014) 329–336.
[8] A.S. Rathore, G. Kapoor, Application of process analytical technology for
downstream puriﬁcation of biotherapeutics, J. Chem. Technol. Biotechnol. 90
(2) (2015) 228–236.
[9] K.B. Konstantinov, C.L. Cooney, White paper on continuous bioprocessing.
May  20–21, 2014 continuous manufacturing symposium, J. Pharm. Sci. 104
(3)  (2015) 813–820.
10] N. Brestrich, T. Hahn, J. Hubbuch, Application of spectral deconvolution and
inverse mechanistic modelling as a tool for root cause investigation in protein
chromatography, J. Chromatogr. A 1437 (2016) 158–167, http://dx.doi.org/10.
1016/j.chroma.2016.02.011.
11] R.L. Fahrner, P.M. Lester, G.S. Blank, D.H. Reifsnyder, Real-time control of
puriﬁed product collection during chromatography of recombinant human
insulin-like growth factor-I using an on-line assay, J. Chromatogr. A 827 (1)
(1998) 37–43.
12] R.L. Fahrner, G.S. Blank, Real-time control of antibody loading during protein
A  afﬁnity chromatography using an on-line assay, J. Chromatogr. A 849 (1)
(1999) 191–196.
13] A.S. Rathore, M.  Yu, S. Yeboah, A. Sharma, Case study and application of
process analytical technology (PAT) towards bioprocessing: use of on-line
high-performance liquid chromatography (HPLC) for making real-time
pooling decisions for process chromatography, Biotechnol. Bioeng. 100 (2)
(2008) 306–316.
14] A.S. Rathore, R. Wood, A. Sharma, S. Dermawan, Case study and application of
process analytical technology (PAT) towards bioprocessing. II: Use of
ultra-performance liquid chromatography (UPLC) for making real-time
pooling decisions for process chromatography, Biotechnol. Bioeng. 101 (6)
(2008) 1366–1374.
15] O. Kaltenbrunner, Y. Lu, A. Sharma, K. Lawson, T. Tressel, Risk-beneﬁt
evaluation of on-line high-performance liquid chromatography analysis for
pooling decisions in large-scale chromatography, J. Chromatogr. A 1241
(2012) 37–45.
16] M.  Krättli, F. Steinebach, M.  Morbidelli, Online control of the twin-column
countercurrent solvent gradient process for biochromatography, J.
Chromatogr. A 1293 (2013) 51–59, http://dx.doi.org/10.1016/j.chroma.2013.
03.069.
17] K.A. Bakeev, Process Analytical Technology: Spectroscopic Tools and
Implementation Strategies for the Chemical and Pharmaceutical Industries,
2nd ed., John Wiley & Sons, 2010.
18] G. Carta, A. Jungbauer, Protein Chromatography: Process Development and
Scale-up, John Wiley & Sons, 2010.
19] B.R. Kowalski, Chemometrics: views and propositions, J. Chem. Inf. Model. 15
(4) (1975) 201–203, http://dx.doi.org/10.1021/ci60004a002.
20] T. Rajalahti, O.M. Kvalheim, Multivariate data analysis in pharmaceutics: a
tutorial review, Int. J. Pharm. 417 (1-2) (2011) 280–290, http://dx.doi.org/10.
1016/j.ijpharm.2011.02.019.Please cite this article in press as: M.  Rüdt, et al., Advances in downstre
analytical technology, J. Chromatogr. A (2016), http://dx.doi.org/10.10
21] L. Eriksson, Multi- and Megavariate Data Analysis, Umetrics AB, 2006.
22] O.M. Kvalheim, Interpretation of direct latent-variable projection methods
and  their aims and use in the analysis of multicomponent spectroscopic and
chromatographic data, Chemom. Intell. Lab. Syst. 4 (1) (1988) 11–25, http://
dx.doi.org/10.1016/0169-7439(88)80009-1.
[ PRESS
. A xxx (2016) xxx–xxx 7
23] O.M. Kvalheim, T.V. Karstang, Interpretation of latent-variable regression
models, Chemom. Intell. Lab. Syst. 7 (1) (1989) 39–51, http://dx.doi.org/10.
1016/0169-7439(89)80110-8.
24] S. Wold, J. Trygg, The PLS method – partial least squares projections to latent
structures – and its applications in industrial RDP (research, development,
and production), in: PLS in Industrial RPD for Prague 1 (June), 2004, pp. 1–44,
http://dx.doi.org/10.1109/JMEMS.2011.2159097.
25] S. Wold, K. Esbensen, P. Geladi, Principal component analysis, Chemom. Intell.
Lab. Syst. 2 (1–3) (1987) 37–52, http://dx.doi.org/10.1016/0169-
7439(87)80084-9.
26] S. Wold, A. Ruhe, H. Wold, W.  Dunn, The collinearity problem in linear
regression. The partial least squares (PLS) approach to generalized inverses,
SIAM J. Sci. Stat. Comput. 5 (3) (1984) 735–743, arXiv:1308.0863v1.
27] H. Martens, T. Naes, Multivariate Calibration, John Wiley & Sons, 1991.
28] S. Wold, J. Trygg, A. Berglund, H. Antti, Some recent developments in PLS
modeling, Chemom. Intell. Lab. Syst. 58 (2) (2001) 131–150, http://dx.doi.org/
10.1016/S0169-7439(01)00156-3.
29] S. Wold, M.  Sjöström, L. Eriksson, PLS-regression: a basic tool of
chemometrics, Chemom. Intell. Lab. Syst. 58 (2) (2001) 109–130, http://dx.
doi.org/10.1016/S0169-7439(01)00155-1, arXiv:S0169-7439 01 00155-1.
30] W.  Kessler, Einführung in die multivariante Datenanalyse, 1st ed., WILEY-VCH
Verlag, Weinheim, 2007.
31] W.  Jiskoot, D. Crommelin (Eds.), Methods for Structural Analysis of Protein
Pharmaceuticals, American Association of Pharmaceutical Scientists, 2005.
32] A. Barth, Infrared spectroscopy of proteins, Biochim. Biophys. Acta 1767 (9)
(2007) 1073–1101, http://dx.doi.org/10.1016/j.bbabio.2007.06.004.
33] J.R. Lakowicz, Principles of Fluorescence Spectroscopy Principles of
Fluorescence Spectroscopy, Springer Science + Business Media, LLC, 2006,
http://dx.doi.org/10.1007/978-0-387-46312-4, arXiv:arXiv:1011.1669v3.
34] R. Schweitzer-Stenner, Advances in vibrational spectroscopy as a sensitive
probe of peptide and protein structure: a critical review, Vib. Spectrosc. 42 (1)
(2006) 98–117.
35] E. Goormaghtigh, V. Cabiaux, J.-M. Ruysschaert, Determination of soluble and
membrane protein structure by fourier transform infrared spectroscopy: I.
Assignment of model compounds, in: Physicochemical Methods in the Study
of  Biomembranes, vol. 23, Springer, 1994, pp. 328–357.
36] S.K. Hansen, B. Jamali, J. Hubbuch, Selective high throughput protein
quantiﬁcation based on UV absorption spectra, Biotechnol. Bioeng. 110 (2)
(2013) 448–460.
37] G.E. Arteaga, Y. Horimoto, E. Li-Chan, S. Nakai, Partial least-squares regression
of fourth-derivative ultraviolet absorbance spectra predicts composition of
protein mixtures: application to bovine caseins, J. Agric. Food Chem. 42 (9)
(1994) 1938–1942.
38] S.K. Hansen, E. Skibsted, A. Staby, J. Hubbuch, A label-free methodology for
selective protein quantiﬁcation by means of absorption measurements,
Biotechnol. Bioeng. 108 (11) (2011) 2661–2669.
39] M.-H. Kamga, H. Woo  Lee, J. Liu, S. Yoon, Rapid quantiﬁcation of protein
mixture in chromatographic separation using multi-wavelength UV spectra,
Biotechnol. Prog. 29 (3) (2013) 664–671.
40] N. Brestrich, T. Briskot, A. Osberghaus, J. Hubbuch, A tool for selective inline
quantiﬁcation of co-eluting proteins in chromatography using spectral
analysis and partial least squares regression, Biotechnol. Bioeng. 111 (7)
(2014) 1365–1373.
41] N. Brestrich, A. Sanden, A. Kraft, K. McCann, J. Bertolini, J. Hubbuch, Advances
in  inline quantiﬁcation of co-eluting proteins in chromatography:
process-data-based model calibration and application towards real-life
separation issues, Biotechnol. Bioeng. 112 (2015) 1406–1416.
42] M.  Rüdt, N. Brestrich, L. Rolinger, J. Hubbuch, Real-time monitoring and
control of the load phase of a protein a capture step, Biotechnol. Bioeng.
(2016), http://dx.doi.org/10.1002/bit.26078/pdf.
43] N. Brestrich, M. Rüdt, D. Büchler, J. Hubbuch, Selective protein quantiﬁcation
for  preparative chromatography using variable pathlength UV/vis
spectroscopy, Biotechnol. Bioeng. (2016) (submitted for publication).
44] F. Capito, R. Skudas, H. Kolmar, C. Hunzinger, Mid-infrared
spectroscopy-based antibody aggregate quantiﬁcation in cell culture ﬂuids,
Biotechnol. J. 8 (8) (2013) 912–917, http://dx.doi.org/10.1002/biot.
201300164.
45] F. Capito, R. Skudas, H. Kolmar, B. Stanislawski, Host cell protein
quantiﬁcation by Fourier transform mid  infrared spectroscopy (FT-MIR),
Biotechnol. Bioeng. 110 (1) (2013) 252–259.
46] F. Capito, R. Skudas, H. Kolmar, C. Hunzinger, At-line mid  infrared
spectroscopy for monitoring downstream processing unit operations, Process
Biochem. 50 (6) (2015) 997–1005, http://dx.doi.org/10.1016/j.procbio.2015.
03.005.
47] C. Walther, S. Mayer, A. Jungbauer, A. Dürauer, Getting ready for PAT: scale up
and  inline monitoring of protein refolding of Npro fusion proteins, Process
Biochem. 49 (7) (2014) 1113–1121, http://dx.doi.org/10.1016/jprocbio.2014.
03.022.
48] M.  Boulet-Audet, S.G. Kazarian, B. Byrne, In-column ATR–FTIR spectroscopy to
monitor afﬁnity chromatography puriﬁcation of monoclonal antibodies, Sci.
Rep. 407 (May) (2016) 7111–7122, http://dx.doi.org/10.1038/srep30526.am processing of biologics – Spectroscopy: An emerging process
16/j.chroma.2016.11.010
49] A.S. Rathore, X. Li, W.  Bartkowski, A. Sharma, Y. Lu, Case study and
application of process analytical technology (PAT) towards bioprocessing:
use of tryptophan ﬂuorescence as at-line tool for making pooling
decisions for process chromatography, Biotechnol. Prog. 25 (5) (2009)
1433–1439.
 ING ModelC
8 atogr
[
[
[
[ARTICLEHROMA-358040; No. of Pages 8
 M. Rüdt et al. / J. Chrom
50] Z. Yu, J.C. Reid, Y.P. Yang, Utilizing dynamic light scattering as a process
analytical technology for protein folding and aggregation monitoring in
vaccine manufacturing, J. Pharm. Sci. 102 (12) (2013) 4284–4290, http://dx.
doi.org/10.1002/jps.23746.Please cite this article in press as: M.  Rüdt, et al., Advances in downstre
analytical technology, J. Chromatogr. A (2016), http://dx.doi.org/10.10
51] A.A. Shukla, U. Gottschalk, Single-use disposable technologies for
biopharmaceutical manufacturing, Trends Biotechnol. 31 (3) (2013) 147–154.
52] K. Watson, B.N. Violand, C. Gallo, S. Sun, R. Godavarti, R.S. Wright, G.R. Bolton,
K.M. Sunasara, J.L. Coffman, Addressing the challenges in downstream
processing today and tomorrow, BioPharm. Int. 24 (2011) 8–15.
[ PRESS
. A xxx (2016) xxx–xxx
53] E. Papamokos, E. Weber, W.  Bode, R. Huber, M.W.  Empie, I. Kato, M.  Laskowski
Jr.,  Crystallographic reﬁnement of Japanese quail ovomucoid, a Kazal-type
inhibitor, and model building studies of complexes with serine proteases, J.
Mol. Biol. 158 (3) (1982) 515–537.am processing of biologics – Spectroscopy: An emerging process
16/j.chroma.2016.11.010
54] A.S. Rose, A.R. Bradley, Y. Valasatava, J.M. Duarte, A. Prlic´, P.W. Rose,
Web-based molecular graphics for large complexes, in: Proceedings of the
21st International Conference on Web3D Technology, Web3D ’16, ACM, New
York, NY, USA, 2016, pp. 185–186, http://dx.doi.org/10.1145/2945292.
2945324.
